Bertrand Audoin
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 151 publications
Fatal cerebral toxoplasmosis in a patient with multiple sclerosis treated with natalizumab.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 18, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.
Journal: Neurology
Published: May 22, 2026
Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 24, 2026
French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.
Journal: Revue neurologique
Published: April 10, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.
Journal: Neurology
Published: April 01, 2026
OCT-defined optic atrophy thresholds are associated with blunted optic nerve swelling in recurrent optic neuritis.
Journal: Multiple sclerosis and related disorders
Published: March 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis.
Journal: Neurology and therapy
Published: March 05, 2026
White and Gray Matter Multiple Sclerosis Spinal Cord Lesion Characteristics and Individualized Tissue Damage Assessment Using 7 T T1 Mapping.
Journal: Investigative radiology
Published: December 19, 2025
Multicenter Assessment of Combined Brain and Cervical Spinal cord 3T MP2RAGE T1 Measurements for Reliable Tissue Microstructure Quantification.
Journal: NMR in biomedicine
Published: December 19, 2025
Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS.
Journal: Annals of clinical and translational neurology
Published: December 18, 2025
Last Updated: 09/26/2026